Breast Cancer Research; Published January 23, 2021
Post# of 148183
(Total Views: 611)
Posted On: 01/25/2021 10:38:19 PM
Breast Cancer Research; Published January 23, 2021.
LERONLIMAB a humanized monoclonal antibody to CCR5 ...BLOCKS breast cancer cellular Metastasis and ENHANCES cell Death induced by DNA damaging chemotherapy.
RESULTS: (a)The binding of LERONLIMAB with CCR5 expressed in Breast Cancer Cells.
(b) The EFFICIENCY of LERONLIMAB binding to CCR5-positive cells was up to 98%.
(c) Leronlimab BLOCKS CCL-3-and CCL4-induced Ca+2 responses in Human breast
cancer cells.
(d) LERONLIMAB BLOCKS CCR5=mediated invasion of human Breast Cancer cells
into the Extra Cellular Matrix.
The words BLOCKS and Enhances appears many times throughout this report..all
pointing in ONE direction.
DR.Acula.....Thanks
LERONLIMAB a humanized monoclonal antibody to CCR5 ...BLOCKS breast cancer cellular Metastasis and ENHANCES cell Death induced by DNA damaging chemotherapy.
RESULTS: (a)The binding of LERONLIMAB with CCR5 expressed in Breast Cancer Cells.
(b) The EFFICIENCY of LERONLIMAB binding to CCR5-positive cells was up to 98%.
(c) Leronlimab BLOCKS CCL-3-and CCL4-induced Ca+2 responses in Human breast
cancer cells.
(d) LERONLIMAB BLOCKS CCR5=mediated invasion of human Breast Cancer cells
into the Extra Cellular Matrix.
The words BLOCKS and Enhances appears many times throughout this report..all
pointing in ONE direction.
DR.Acula.....Thanks
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼